Evolution of chronic skin diseases
Part of Skin clinical trials.
This trial looks at how well standard treatments work for chronic skin conditions like atopic dermatitis, prurigo nodularis, psoriasis, chronic hand eczema, and hidradenitis suppurativa. It's observational, so it just tracks your progress during your normal care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 12 years old or older
- Diagnosed with one of these skin conditions: atopic dermatitis, prurigo nodularis, psoriasis, chronic hand eczema, or hidradenitis suppurativa
- Attending the dermatology clinic at the Policlinico Gemelli in Rome
- Having medical records that include starting treatment date and at least one follow-up visit with a clinical score
- Able to understand and sign an informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long people with moderate to severe eczema stay on newer targeted medicines (biologics or pills). By reviewing medical records, researchers hope to learn which treatments work best over time and how they are used in real life.
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study looks at the health records of people with certain inflammatory skin diseases (such as psoriasis or eczema) in Italy to understand who gets them and what treatments they receive. By joining, you help doctors learn more about how these conditions are managed in real life.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
Hear when a new Inflammatory Skin Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.